October 14, 2021
4G Clinical Nominated for Powerhouse Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
WELLESLEY, Mass. – October 14, 2021 – Today, 4G Clinical announced that it has been shortlisted for the Powerhouse Company of the Year Award in the 2021 NEVY Awards, hosted by the New England Venture Capital Association (NEVCA) and presented by Dell Technologies. The NEVYs, now in their ninth year, celebrate New England’s top innovators, investors and companies across the region’s healthcare, life science, tech, medtech, and cleantech communities. Final winners will be revealed via a dynamic live broadcast and live at the House of Blues Boston on December 2, 2021, at 6:30pm.
“The 2021 Powerhouse Company of the Year nomination is a tremendous honor for 4G Clinical, adding to a year that has already seen unparalleled growth and accomplishment for our company,” said David Kelleher, CEO, 4G Clinical. “Investment in the pharmaceutical sector, specifically clinical trials, is more important than ever before. As a proud member of New England’s burgeoning biotech community, we are doing our part to bring crucial medicines to those who need them, faster.”
With a focus on the regional business community, nominees – selected by the NEVYs Academy, composed of investors from the region’s top venture capital firms – are both locally headquartered and locally backed. The Powerhouse Company of the Year nomination goes to companies exemplifying New England’s leading place in the industry.
"The NEVYs were born out of a desire to shine a spotlight on the amazing companies and breakthroughs happening in New England, with each year seeming like the nominees are even more impressive than the last," said Jody Rose, President of the NEVCA. "That’s certainly no exception with our nominated companies for 2021, whose achievements in their respective fields are truly outstanding. We look forward to showcasing each of them at our December 2nd event and celebrating the continued strength and vitality of this region’s innovation ecosystem."
Learn more about the 2021 NEVY Awards at www.thenevys.com.
About 4G Clinical
4G Clinical is a global leader in randomization and trial supply management (RTSM) for the life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) to accelerate clinical trials. 4G Clinical is headquartered in the U.S., within the Boston Biotech corridor of Wellesley, Massachusetts, and a West Coast office in Portland, Oregon. The company also maintains eight additional locations worldwide, with offices in Tokyo, Amsterdam, Dublin, Brussels, Tel Aviv, Basel, Nottingham, and Rheinbach. Learn more at www.4gclinical.com.
About the New England Venture Capital Association
The New England Venture Capital Association (NEVCA) works toward a collaborative, inclusive, and prosperous innovation ecosystem. Through unique program-building, critical policy work, innovative regional marketing, and dynamic local events, the NEVCA invests in the entrepreneurial ecosystem on behalf of the VC community. From celebrations (the NEVY Awards) to content series (VC Briefings and Syndicate Sessions), workforce development programs (Hack.Diversity and the Bioscience & Investor Inclusion Group) to advocacy and legislation (non-compete and immigration reform), the NEVCA is at once a network, catalyst, and resource for the innovation economy.
Tag(s): Press Releases
Related Blog Posts HeadlineView All Blog Posts
May 16, 2019
EY Announces David Kelleher and Ed Tourtellotte of 4G Clinical as Entrepreneur Of The Year® 2019 Award Finalists in New EnglandRead More
October 2, 2018
Clarkston Consulting and 4G Clinical Form New Partnership to Advance Clinical Trial OperationsRead More
October 27, 2021